Archive | Evercyte GmbH
Evercyte teams with Phoenestra and TAmiRNA to offer EVs at scale
Tuesday 23rd April 2024
Learn More >
Evercyte contributing to reduced animal testing at key events
Thursday 30th November 2023
Learn More >
Evercyte promoting telomerized cell advantages at Small New World symposium
Thursday 24th August 2023
Learn More >
Evercyte immortalized cell lines compatible with OOAC organ on chip technology
Wednesday 2nd August 2023
Learn More >
Evercyte EVs from human bone marrow-derived MSC (EV-BM-MSC/TERT292)
Tuesday 11th July 2023
Learn More >
Evercyte brings EV and senescent cell expertise to EU Horizon CHANGE project
Friday 28th April 2023
Learn More >
Evercyte showing EV cell factory capabilities at IGLD Symposium Frankfurt
Friday 17th March 2023
Learn More >
Evercyte synoviocyte and chondrocyte bioassays target osteoarthritis
Friday 24th February 2023
Learn More >
Evercyte senolytic and senomorphic drug testing using cell-based assays
Friday 13th January 2023
Learn More >